J&J Covid shot pause will delay U.S. vaccination efforts, says Dr. Kavita Patel


ORLANDO, FLORIDA, UNITED STATES – 2021/04/10: Johnson & Johnson COVID-19 vial and field seen at a vaccination web site.
Doses of the Johnson & Johnson vaccine are being administered all through the state of Florida regardless of a small variety of sufferers who’ve skilled hostile reactions, together with blood clots. (Photograph by Paul Hennessy/SOPA Photos/LightRocket through Getty Photos)

SOPA Photos | LightRocket | Getty Photos

Dr. Kavita Patel informed CNBC on Tuesday she believes the Meals and Drug Administration’s advice that states pause the use of Johnson & Johnson‘s single-shot Covid vaccine is prone to have lasting impacts on the nation’s efforts to fight the pandemic.

“This can be a devastating blow to this J&J vaccine effort in america,” Patel, a main care doctor in Washington, D.C., stated in an interview on “Squawk Box.”

Patel stated the availability of the two-shot vaccines from Pfizer and Moderna will not have the ability to rapidly make up the demand created by the J&J pause. This can delay U.S. vaccination efforts, she added.

The FDA’s advice, issued earlier Tuesday, got here after six folks within the U.S. developed uncommon and extreme blood clotting points after they’d obtained the vaccine.

In a tweet, the U.S. regulator stated it is motion was being taken “out of an abundance of warning.”

All six instances occurred in girls between the ages of 18 and 48, with signs creating six to 13 days after they obtained the shot.

As of now, J&J stated there’s “no clear causal relationship” between these uncommon occasions and the vaccine. The U.S. drug big additionally stated it is working with regulators.